UnitedHealth Projects Growth Despite COVID Costs, Plus Tech Investment in 2021

At its annual investor day on Dec. 1, UnitedHealth Group predicted that it will incur $2 billion in extra, incidental expenditures in 2021 caused by the ongoing COVID-19 pandemic. Still, Wall Street analysts agreed with UnitedHealth executives’ overall bullish outlook, citing the payer-provider giant’s projected growth in Medicare Advantage (MA) enrollment and ongoing strong returns from its OptumHealth provider segment.

Citi analyst Ralph Giacobbe wrote in a Dec. 2 investor note that he was convinced by UnitedHealth executives’ assertions that COVID-19 held back projected 2021 revenue growth, and he anticipated “a higher baseline to consider when contemplating future years.”

0 Comments
© 2022 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

person-holding-a-pencil
September 30

Medicaid Plans Aren’t Properly Reporting MLR Data, OIG Finds

READ MORE
stethoscope-bill-and-pills
September 30

How Would Adjusting the Marketplace Coverage Benchmark to a Gold Plan Affect Affordability?

READ MORE
department-of-justice-building
September 30

Loss in UnitedHealth/Change Trial May Not Lower DOJ’s Deal-Blocking Appetite

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today